Nisa Investment Advisors
ALDX icon

Nisa Investment Advisors’s Aldeyra Therapeutics ALDX Stock Holding History

Nisa Investment Advisors’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$392 Sell
184
-4,416
-96% -$7.59K ﹤0.01% 2973
2026
Q1 		$7.77K Buy
4,600
+4,503
+4,642% +$19.7K ﹤0.01% 2328
2025
Q4 		$502 Hold
97
– – ﹤0.01% 2818
2025
Q3 		$506 Hold
97
– – ﹤0.01% 2858
2025
Q2 		$372 Sell
97
-1,533
-94% -$3.96K ﹤0.01% 2916
2025
Q1 		$9.37K Buy
1,630
+49
+3% +$290 ﹤0.01% 2110
2024
Q4 		$7.89K Buy
1,581
+88
+6% +$452 ﹤0.01% 2183
2024
Q3 		$8.05K Buy
1,493
+42
+3% +$200 ﹤0.01% 2133
2024
Q2 		$4.8K Buy
1,451
+1,396
+2,538% +$5.47K ﹤0.01% 2273
2024
Q1 		$180 Buy
55
+15
+38% +$49 ﹤0.01% 2658
2023
Q4 		$140 Buy
+40
New +$123 ﹤0.01% 2595
2022
Q2 		– Sell
-50,600
Closed -$225K – 2370
2022
Q1 		$225K Buy
+50,600
New +$202K ﹤0.01% 1336

Other funds holding ALDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Nisa Investment Advisors's ALDX Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Aldeyra Therapeutics (ALDX) stake by 96% in Q2 2026, selling an estimated $7.59K and leaving 184 shares worth $392. The position accounts for ﹤0.01% of the portfolio, ranked #2973.

Nisa Investment Advisors first reported a position in ALDX in Q1 2022 and has held it in 12 quarters since. The position peaked at $225K in Q1 2022. 36 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Nisa Investment Advisors held 184 shares of Aldeyra Therapeutics worth $392 as of Q2 2026.
  • Nisa Investment Advisors sold 4,416 Aldeyra Therapeutics shares in Q2 2026, an estimated $7.59K.
  • Aldeyra Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2973 holding.
  • Nisa Investment Advisors first reported a position in Aldeyra Therapeutics in Q1 2022 and has held it in 12 quarters since.
  • Nisa Investment Advisors's Aldeyra Therapeutics position peaked at $225K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.